Guardian Pharmacy Services Inc. has announced the pricing of its underwritten public offering of 7,500,000 shares of Class A common stock at $21.00 per share. Of these, 6,059,553 shares are being sold by certain stockholders, while 1,440,447 shares are part of a non-dilutive "synthetic secondary" transaction, which involves Guardian using the proceeds to repurchase the same number of shares. This approach ensures that the total number of outstanding shares remains unchanged. The offering, led by Raymond James with participation from Stephens Inc. and Truist Securities, is expected to close on May 27, 2025, pending customary conditions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardian Pharmacy Services Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250522081313) on May 23, 2025, and is solely responsible for the information contained therein.